COMP and hepatocellular carcinoma: Sub-analysis, comparing only GP73(+)/COMP(+) vs. GP73(+)/COMP(−) and GP73(+)/COMP(+) vs. GP73(−)/COMP(+), further verified the higher performance of dual positivity in predicting development of HCC during follow-up (Kaplan-Meier analysis; P = 0.005 and P = 0.001, respectively).